Uveitis Treatment Market Size to hit USD 809.7 Million in 2028 | Growing at 5.7% CAGR, Says Brandessence Market Research

LONDON, April 21, 2022 /PRNewswire/ -- The Uveitis Treatment Market size is expected to Reach USD 809.7 Million by 2028, Registering to Accelerate at a 5.7% CAGR, According to the most recent study by Brandessence Market Research & Consulting Pvt ltd.

BEMR_Logo

The Global Uveitis Treatment Market size was Valued at USD 549.3 Million in 2021. Increasing demand for advanced healthcare products and the rising number of patients affected by Cataracts and other eye-related diseases are some factors driving the growth of Global Market. "Uveitis Treatment Market Size, Share & Trends Analysis Report By Product Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Store) Based On Region, And Segment Forecasts, 2022 - 2028"

Get Sample of Report@ https://brandessenceresearch.com/requestSample/PostId/554

Uveitis Treatment Market Scope of Report

Uveitis disease directly affects the eyes and the most common symptoms of uveitis are eye inflammation and swelling that can destroy eye tissues. Whether it's human's eye or any animals', uveitis affects everyone and can lead to poor vision or blindness. It is named as uveitis because mostly the swelling affects the part of eye which called uvea. Basically eye is made of several layers and uvea is the middle layer, it's between white part of eye and the inner layers of eye which called the sclera. Uvea has three important structures the iris, the ciliary body and the choroid. The Iris is colored circle at the front of eye, the ciliary body helps to focus eye lens and makes fluid that nourishes inside of eye and the choroid is group of blood vessels which gives the nutrition's to the retina it needs. People who are suffering from AIDS, Ankylosing spondylitis, Behcet's disease, CMV retinitis, Herpes zoster infection, Histoplasmosis, Kawasaki disease, Multiple sclerosis, Psoriasis, Reactive arthritis, Rheumatoid arthritis etc. have greater risk of having uveitis than normal people.

Uveitis Treatment Key Players:

  • Allergan
  • Bausch & Lomb
  • Novartis
  • AbbVie
  • Santen Pharmaceutical
  • Eyegate Pharmaceuticals
  • Alimera Sciences
  • And More
Global Uveitis Treatment Market Segmentation:

By Product Type:

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

By Application:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Store

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/554

Advanced technological requirements in healthcare, increasing disposable income and high expenditure on healthcare are some of the factors driving the market of uveitis treatment. Uveitis can affect eyes through dirt, pollution, viral, fungal, bacterial infections, etc. and uveitis cause cataract. Cataract is responsible for worlds around 51% of blindness which is about 20 million people. Smokers have more risk of uveitis and of blindness. There are around 1.2 million people who are smokers, there is a huge number of smokers some of them are suffering from diseases and 80% of them are from low and middle income countries. Thus, all these factors are expected to foster the growth of this market.

However, high cost of treatment and lack of skilled professionals can restrain the market growth. In spite of this, technological advancement, increasing numbers of hospitals, diagnostic centers, online treatments are some factors which can provide various opportunities for the further growth of the market.

North America is Expected to Dominate the Global Uveitis Treatment Market.

North America is expected to dominate the Global Uveitis Treatment owing to the high investment in this field. In addition, research and development by leading players to develop new innovative products in this region is also fostering the market growth. For example, Allergan expanded REFRESH portfolio with new REFRESH, RELIEVA Lubricant Eye Drop Product Line. The annual direct medical cost in the US is estimated to USD 117 million. Uveitis accounts 10% of blindness globally. 60%-80% uveitis patient occur in patient in third to sixth decade of life with an age of occurrence of 35. The prevalence of uveitis is estimated 17 per 100000 in Europe which is comparable to the US. Uveitis is one of the major reasons for the birth of cataract and it accounts for 30%–50% of blindness in most Asian countries.

On Special Requirement Uveitis Treatment Market Report is also available for below region:

North America

  • U.S, Canada

Europe

  • Germany, France,U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

  • South_Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Get Full Access of all Report: https://brandessenceresearch.com/healthcare/uveitis-treatment-market-size

Related Reports: 

  • Antihypertensive Drugs Market to hit USD 29.35 Billion in 2028
  • EMI Shielding Market Size to hit USD 11 Billion in 2028
  • Meningococcal Vaccines Market to hit USD 4.87 Billion in 2028
  • Application Security Market Size to Hit USD 20880.7 Million in 2028
  • Silicon Photonics Market Size is Expected to Reach USD 7253.6 Million in 2028
  • Automotive Diagnostic Scan Tools Market Size to hit USD 46.17 Billion in 2028
  • Point of care Ultrasound Market Size to hit USD 5089.2 Million in 2028
  • Dietary Fiber Market size is estimated to grow at a CAGR of 12.9% by 2027
  • Citrus Oil Market Size is projected to Garner $ 9.06 Billion in 2028
  • Avocado Oil Market 2022: Global Key Players, Trends, Share, Industry Size, Segmentation, Forecast To 2028
  • Shea Butter Market Scenario & Prominent Key Players Analysis 2022 to 2028 | Shea Radiance, Star Shea
  • Pulmonary Function Testing Systems Market Size To Cross $776.1 Million by 2028
  • Color Cosmetics Market size to hit USD 112.90 Billion in 2028
  • CRM Software Market to hit USD 100.63 Billion in 2028

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, chang ing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic.  Register for free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website: https://brandessenceresearch.com 

Blog: Warehouse Automation Companies

Follow Us: Linkedin  

Mr. Vishal Sawant 
Email:
 vishal@brandessenceresearch.com 
Email: Sales@brandessenceresearch.com 
Corporate Sales: +44-2038074155
Asia Office: +917447409162

Cision View original content:https://www.prnewswire.com/news-releases/uveitis-treatment-market-size-to-hit-usd-809-7-million-in-2028--growing-at-5-7-cagr-says-brandessence-market-research-301530125.html

SOURCE Brandessence Market Research And Consulting Private Limited

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.